The changing field of vaccine development in the genomics era.
暂无分享,去创建一个
[1] J. Sidney,et al. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.
[2] Vladimir Brusic,et al. Bioinformatics tools for identifying T-cell epitopes , 2004 .
[3] James Robinson,et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..
[4] F. André,et al. Vaccinology: past achievements, present roadblocks and future promises. , 2003, Vaccine.
[5] Gregory A Poland,et al. Variation in vaccine response in normal populations. , 2004, Pharmacogenomics.
[6] Vladimir Brusic,et al. Prediction of class I T-cell epitopes: evidence of presence of immunological hot spots inside antigens , 2004, ISMB/ECCB.
[7] A. Fauci,et al. The challenge of emerging and re-emerging infectious diseases , 2004, Nature.
[8] J. Ehreth. The global value of vaccination. , 2003, Vaccine.
[9] R. Valenta,et al. Strategies for converting allergens into hypoallergenic vaccine candidates. , 2004, Methods.
[10] H. Ploegh,et al. Translating cell biology in vitro to immunity in vivo , 2004, Nature.
[11] Edouard Kurstak,et al. Towards the new global vaccinology era in prevention and control of diseases. , 2003, Vaccine.
[12] J. Berzofsky,et al. Progress on new vaccine strategies for the immunotherapy and prevention of cancer. , 2004, The Journal of clinical investigation.